Compare, Analyse GSK Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs MYLAN (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   MYLAN
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
MYLAN
Dec-18
GSK PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,5953,480-   
Low Rs1,2531,915-   
Sales per share (Unadj.) Rs184.71,601.1-  
Earnings per share (Unadj.) Rs26.343.5-  
Cash flow per share (Unadj.) Rs29.2343.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.31,732.1-  
Shares outstanding (eoy) m169.40514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x13.11.7 779.2%   
Avg P/E ratio x92.262.0 148.6%  
P/CF ratio (eoy) x83.17.9 1,057.8%  
Price / Book Value ratio x19.21.6 1,232.2%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6261,387,807 29.6%   
No. of employees `0005.035.0 14.2%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.723,536.1 26.8%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0639.1 140.5%   
INCOME DATA
Net Sales Rs m31,281823,764 3.8%  
Other income Rs m1,0230-   
Total revenues Rs m32,304823,764 3.9%   
Gross profit Rs m6,009213,160 2.8%  
Depreciation Rs m486154,241 0.3%   
Interest Rs m639,620 0.0%   
Profit before tax Rs m6,54019,298 33.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373-3,070 -77.3%   
Profit after tax Rs m4,45422,369 19.9%  
Gross profit margin %19.225.9 74.2%  
Effective tax rate %36.3-15.9 -228.1%   
Net profit margin %14.22.7 524.4%  
BALANCE SHEET DATA
Current assets Rs m20,061459,989 4.4%   
Current liabilities Rs m14,543335,383 4.3%   
Net working cap to sales %17.615.1 116.6%  
Current ratio x1.41.4 100.6%  
Inventory Days Days5784 67.9%  
Debtors Days Days1493 15.1%  
Net fixed assets Rs m14,343159,797 9.0%   
Share capital Rs m1,694439 386.2%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,398891,162 2.4%   
Long term debt Rs m2961,850 0.0%   
Total assets Rs m39,1132,390,443 1.6%  
Interest coverage x1,091.01.5 73,365.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 232.1%   
Return on assets %11.42.6 439.7%  
Return on equity %20.82.5 829.3%  
Return on capital %31.93.2 1,004.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994171,178 2.3%  
From Investments Rs m-1,433-88,480 1.6%  
From Financial Activity Rs m-3,584-79,745 4.5%  
Net Cashflow Rs m-1,0231,418 -72.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.1 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: CIPLA  DR. DATSONS LABS  SUVEN LIFE SCIENCES  WYETH  CADILA HEALTHCARE  



Today's Market

Sensex, Nifty End at Record Closing High; Tata Steel and Coal India Among Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules (Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

Is the RBI's 'Bubble Talk' Signalling a Market Crash? (Profit Hunter)

May 31, 2021

Is the Indian central bank correct in warning you about a market crash?

Rs 2 Trillion Stimulus Coming to a Stock Market Near You (Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


Jun 11, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 5-YR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS